RJA
CVS icon

Raymond James & Associates’s CVS Health CVS Stock Holding History

Raymond James & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,300
Closed -$384K – 3865
2023
Q1 		$384K Buy
+5,300
New +$444K ﹤0.01% 3076

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Raymond James & Associates's CVS Position: Q3 2024 in Review

Raymond James & Associates reduced its CVS Health (CVS) stake by 11% in Q3 2024, selling an estimated $14.3M and leaving 2,041,004 shares worth $128M. The position accounts for 0.08% of the portfolio, ranked #213.

Raymond James & Associates first reported a position in CVS in Q2 2013 and has held it in 46 quarters since. The position peaked at $353M in Q4 2021. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Raymond James & Associates held 2,041,004 shares of CVS Health worth $128M as of Q3 2024.
  • Raymond James & Associates sold 245,468 CVS Health shares in Q3 2024, an estimated $14.3M.
  • CVS Health made up 0.08% of Raymond James & Associates's portfolio in Q3 2024, its #213 holding.
  • Raymond James & Associates first reported a position in CVS Health in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's CVS Health position peaked at $353M in Q4 2021.
  • 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.